Top Story

FDA approves contact force-sensing ablation catheter

November 1, 2014

St. Jude Medical Inc. announced that it has received FDA approval for an irrigated ablation catheter for the treatment of atrial fibrillation.

The TactiCath Quartz contact force ablation catheter is intended to allow greater control over the amount of force applied to the heart wall during ablation for paroxysmal AF, resulting in the creation of more effective lesions, according to a press release.

Aesculap announces first human implantation of Novocart 3-D

November 1, 2014
Aesculap Biologics recently announced that the first clinical study patient was implanted with the company’s Novocart 3-D product.
figure In the Journals

Lung cancer clinical trials routinely exclude cancer survivors

October 31, 2014
Many patients are automatically excluded from lung cancer clinical trials due to previous cancer, according to findings.Additionally, this criterion appears to be used…
figure Meeting News CoverageVideo

Triglycerides examined as potential CV therapy target

October 31, 2014
BOSTON — In this video, Cardiology Today Editorial Board member Michael H. Davidson, MD, highlights a symposium at the Cardiometabolic Health Congress that…
More News Headlines »
CME
figure

In Focus: Advances in AMD – Current, Emerging, and Future Strategies for the Management of Dry AMD

This activity is supported by an educational grant from Genentech, Inc.

Dry age-related macular degeneration has proven to be a challenging condition for clinicians, and no pharmaceutical…
More »
Case Report

Spectral-Domain Optical Coherence Tomography of Sympathetic Ophthalmia With Dalen–Fuchs Nodules

Ophthalmic Surgery, Lasers and Imaging Retina
Online Advanced Release, October 29, 2014
The authors present a case of sympathetic ophthalmia with Dalen–Fuchs nodules visualized with spectral-domain optical…
More »
Meeting News Coverage Video
figure

Triglycerides examined as potential CV therapy target

October 31, 2014
BOSTON — In this video, Cardiology Today Editorial Board member Michael H. Davidson, MD, highlights a symposium…
More »